chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a consumer concerning her 18 month old son who was vaccinated with hep B vaccine, prior to six months of age. Concomitant therapy included at least one immunization containing thimerosal at less than six months of age. On approximately 04/14/2002, at 17 months old, medical attention was sought and the pt was diagnosed with autism. The mother reported that she first noticed a "change" in her son at six months and has refused other vaccines since that time due to her concerns about safety. The mother expressed a concern regarding the lot numbers containing heavy metals or preservative. Upon internal review, autism was considered an other important medical event. Additional info has been requested.
pt recvd vax & fainted; mom was able to catch pt in arms; nurse carried pt back into clinical area; pt awake @ time but disoriented; appeared pale & cyanotic around the lips;
High fever, projectile vomiting, lethargic, dehydration, stopped breathing while sleeping - we were able to resuscitate him, lips turned blue.
Developed bilateral hand swelling with itching. Lip swelling. No oral or pharyngeal swelling.  No shortness of breath. No rash. Went to emergency room and was given methylprednisolone 125 mg IV; famotidine 20 mg IV and diphenhydramine 50 mg IV. Discharged from emergency room with prescriptions for prednisone 20 mg 3 tabs dly for 3 days, diphenhydramine 25 mg PRN, famotidine 40 mg 1 tab daily.
It started one week after I had the shot; my whole left arm, left shoulder, and underneath my arm were sore. The pain was getting worse, so I contacted my doctor. When I checked with Dr., he stated it could be nerve pain and gave me prednisone. The next morning, I noticed a rash on my shoulder. I sent my doctor a picture and he told me it was shingles. My doctor prescribed me Valacyclovir. The pain had gotten worse, so my doctor prescribed gabapentin for 3 days a week. My whole arm has now broken out in a rash, across my back, and into my hand. I am still taking the pain pills.
diagnosed with shingles on her midsection; This case was reported by a pharmacist and described the occurrence of shingles in a 74-year-old female patient who received Herpes zoster (Shingrix) (batch number H4H34, expiry date 27th November 2021) for prophylaxis.   On 13th November 2020, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On 22nd December 2020, 39 days after receiving Shingrix, the patient experienced shingles. The patient was treated with famciclovir. Shingrix was interrupted. On an unknown date, the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient received the Shingrix in left arm. On 22nd December 2020, she was diagnosed with shingles on her midsection and started on antivirals (famciclovir 500 mg TID  for 7days).  She was advised by her physician to not receive the 2nd dose of Shingrix. This case had been linked with US2020220506 and US2020220495 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020220506:same reporter US-GLAXOSMITHKLINE-US2020220495:same reporter
Almost immediately after the shot the area started to itch. after about 10 minutes more and more of my body started to itch. it has been almost 4 days and my whole body is itching with hives in certain places like the back of my head, neck, breast area. I have been trying to take Benadryl to help but it isn't helping much. as of today (9/22/2021 at 12:45pm) I am still having full body itching. If it continues tomorrow I am going to make a doctors visit.
Fever cough  sneezing  Nausea  Vomiting  Diarrhea
Fever, chills, muscle aches, malaise, onset 6:00pm, resolved by 8:00 am the next day.
Patient received vaccine on 12/17 and developed headache, myalgias, nausea, vomiting, fever, and chills several hours after his shot. Nausea and vomiting persisted and worsened on 12/18. Evening of 12/18 he developed several epigastric and left sided abdominal pain and presented to the emergency room on 12/19.
neuralgia has greatly improved; tiny bit of itching due to her neuralgia; This case was reported by a consumer via call center representative and described the occurrence of unexpected therapeutic effect in a 73-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles. Concurrent medical conditions included neuralgia (has had shingles in the past which resulted in her suffering from neuralgia). Concomitant products included PNEUMOCOCCAL VACCINE (PNEUMONIA VACCINE).   In January 2020, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than 5 months after receiving Shingrix, the patient experienced unexpected therapeutic effect and pruritus. On an unknown date, the outcome of the unexpected therapeutic effect and pruritus were unknown.   It was unknown if the reporter considered the unexpected therapeutic effect and pruritus to be related to Shingrix.  Additional details were reported as follows: The patient stated after getting her first dose of Shingrix in January of this year, her neuralgia had greatly improved.  The patient stated that on occasion, she gets a tiny bit of itching due to her neuralgia and she might take Lyrica once every 3 weeks or every month at 50 mg for it.  The patient also mentioned that she received the pneumonia vaccine on the same day of Shingrix but in the right arm. The patient did not want to share her healthcare provider's information at this time but did consent to having the form mailed to her, the patient. The reporter consented to follow up.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36-year-old male patient received BNT162b2 (BNT162B2), on 14Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 36 years for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: COVID 19 Treatment; (27May2022) Negative; (31May2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical course: No other medication received in 2 weeks. Treatment of COVID-19 with Paxlovid Brand Treatment start date from 22May2022, Treatment stop date: 27May2022.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fully vaccinated subject developed headache and nasal congestion, with mild cough and temp of 100.0 on 3/1/2021.  A rapid test on 3/4 was positive for COVID, but no household contacts were positive (husband and 2 children).  Symptoms have improved; she only has rhinorrhea at this time.   She plans to get a repeat PCR this week to confirm her test result The patient is awaiting bariatric surgery- our software does not capture any information about what type of needle was used.   I spoke to the nurse who is our head of operations- she will reinforce the need for longer needles for morbidly obese patients.
7 hours after the 2nd dose, I felt regular symptoms such as fever, aches, and headache. My fever reached 101 at it's peak but Motrin reduced it. Symptoms got a lot worse 12 hours after. These symptoms ended almost exactly 24 hours later, around 11pm the following day.  However, 24 hours after the symptoms arose,  I noticed a patchy, itchy rash covering the left side of my stomach. After the first dose, I had gotten a small circular rash on my left forearm, but at the time did not realize that was a symptom. After the 2nd dose,  the spot on my left forearm came back and was bigger. I was generally itchy and the next day noticed the rash had spread a tiny bit to my lower back.   It has been 2 weeks and my rash is still present, but significantly faded. It only itches when I touch it.
1:55 pt weak, dizzy, diaphoresis, pallor. 1:56  VSS, lie down - laying down 25 min all Sx resolved.
When dose was administered, needle detached from the syringe.  This led to some vaccine on the patients arm and an improper amount of vaccine administered.
Raised, red area at injection site, "itching"; no medications given (child at school, area marked on skin by school nurse; no hives or breathing problems reported.
I had just a little sore arm; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (134184). The reporter is the patient.  A 67 year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "I had just a little sore arm". It was unknown if therapeutic measures were taken as a result of pain in extremity.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
10 minutes after vaccination patient felt tingling sensation in Left Arm and numbness in finger. Pt was observed closely and then went to bed after 1/2 hours of receiving vaccine
I got COVID; It started with my nose burning; sore arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I got COVID), BURNING SENSATION (It started with my nose burning) and VACCINATION SITE PAIN (sore arm at the injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Aug-2021, the patient experienced VACCINATION SITE PAIN (sore arm at the injection site). On 17-Aug-2021, the patient experienced COVID-19 (I got COVID) and BURNING SENSATION (It started with my nose burning). At the time of the report, COVID-19 (I got COVID), BURNING SENSATION (It started with my nose burning) and VACCINATION SITE PAIN (sore arm at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  The patient had a sore arm at the injection site.   On 17-Aug-2021, the patient had positive diagnosis of Covid-19. "My test came back positive." "It started with my nose burning. I thought I had a sinus infection. I had congestion, a fever for 2-3 days" (she didn't take her temperature), "and I lost taste and smell for just a few days."  No treatment information was provided.  Company Comment: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
Fever, chills, headache onset 8 hours post vaccination, resolved 12 hours after onset.  Tightness in chest with deep breathing and dry cough onset 8 hours post vaccination, still present 6 days post vaccination with no improvement.
Information has been received from an RN concerning a school aged male child who in approximately 1999 was vaccinated with varicella virus vaccine live. On approximately 12/14/01, the child developed chickenpox. Unspecified medical attention was sought. At the time of this report, no further details were provided and the outcome of the event was unknown. Additional information has been requested.
flu like symptoms; dizziness; tiredness; headache; muscle aches; joint aches; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 53-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 30th October 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, less than a week after receiving Shingrix, the patient experienced influenza-like symptoms, dizziness, tiredness, headache, muscle pain and joint pain. In November 2019, the outcome of the influenza-like symptoms, dizziness, tiredness, headache, muscle pain and joint pain were recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms, dizziness, tiredness, headache, muscle pain and joint pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received the 1st dose of Shingrix vaccine and had experienced flu like symptoms, dizziness, tiredness, headache, muscle aches and joint aches. The patient states that the symptoms resolved sometime between 6th November 2019 and 7th November 2019. The reporter denied consent to follow up.
A Series of patients aprox 540 patients received past its 30 days expired date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (A Series of patients aprox 540 patients received past its 30 days expired date.) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2022 at 12:11 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 11-Mar-2022 at 12:11 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (A Series of patients aprox 540 patients received past its 30 days expired date.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (A Series of patients aprox 540 patients received past its 30 days expired date.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant product use was reported.  The patient received vaccine past its 30 day expiry date The vaccine went into 28 degree Celsius thaw date on or about 20-DEC-2021. The vaccine was administered up until it manufactured expiry date of 04-Apr-2022. The patient received booster dose.  No treatment information was provided.
Pt received Anthrax and Typhoid vaccines in seated position. Following administration, patient talked to technician about signs and symptoms, vaccine schedules and his deployment checklist. Pt felt light headed and was heading towards the table when he had a vasovagal reaction. Pt was caught and placed on a table in the supine position with his legs rasied while he was evaluated by the nurse and technician. Blood pressure was taken and patient was monitored. Pt was then placed in the sitting position for the next 15 minutes while he was evaluated by the nurse and provider. Patient was later released without any physical treatments.
Diarrhea; muscle & joint aches; muscle & joint aches; fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 82-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 07Oct2022 at 16:00 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 82 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Arthritis" (unspecified if ongoing). Concomitant medication(s) included: MELOXICAM; PRILOSEC [OMEPRAZOLE MAGNESIUM]. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 immunization; Covid-19 vaccine (DOSE 3; MANUFACTURER UNKNOWN), for COVID-19 immunization. The following information was reported: DIARRHOEA (non-serious) with onset 08Oct2022 at 12:00, outcome "recovered" (Oct2022), described as "Diarrhea"; FATIGUE (non-serious) with onset 08Oct2022 at 12:00, outcome "recovered" (Oct2022); MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset 08Oct2022 at 12:00, outcome "recovered" (Oct2022) and all described as "muscle & joint aches". Therapeutic measures were not taken as a result of diarrhoea, myalgia, arthralgia, fatigue. Additional information: The patient did not have covid prior vaccination and has not been tested for COVID-19 post vaccination.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
arm swelled up; Initial information was received on 13-Oct-2020 regarding an unsolicited valid non-serious case from a consumer (patient) via social media.  This case involves a patient (unknown age and gender) whose arm swelled up and missed work for a week (peripheral swelling) after he/ she received INFLUENZA VACCINE.  The patient's medical history, past medical treatments, concomitant therapy, and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient's arm swelled up (peripheral swelling) (Unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, outcome of the event was unknown.  There would be no information available on lot number for this case.
sore in his left arm which moved to his right breast; underneath arm lymph nodes are swollen; sore in his left arm; severe joint pain; lethargic; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (lethargic), BREAST PAIN (sore in his left arm which moved to his right breast), ARTHRALGIA (severe joint pain), LYMPHADENOPATHY (underneath arm lymph nodes are swollen) and VACCINATION SITE PAIN (sore in his left arm) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019F21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (believed he already had COVID 2 1/2 months ago.).    On 29-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Sep-2021, the patient experienced LETHARGY (lethargic) and ARTHRALGIA (severe joint pain). On 01-Oct-2021, the patient experienced BREAST PAIN (sore in his left arm which moved to his right breast), LYMPHADENOPATHY (underneath arm lymph nodes are swollen) and VACCINATION SITE PAIN (sore in his left arm). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Symptomatic treatment, at an unspecified dose and frequency. At the time of the report, LETHARGY (lethargic), BREAST PAIN (sore in his left arm which moved to his right breast), ARTHRALGIA (severe joint pain), LYMPHADENOPATHY (underneath arm lymph nodes are swollen) and VACCINATION SITE PAIN (sore in his left arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported not being on any medications prior to getting vaccine.
Information has been received from a registered nurse and physician concerning a 7-year-old male with no known allergies or past medical history who on 29-JUN-2000 was vaccinated in the right thigh with a 0.5 first dose of Varivax (lot# 632718/1856J). Concomitant vaccination included a first dose of MMR II (lot # 632456/0173K) given in the left thigh. No rash occurred at the injection site or elsewhere within 42 days of vaccination. On 19-AUG-2006 the patient experienced left arm pain. On 20-AUG-2006, the patient developed a "herpes zoster rash" on his left arm. On 22-AUG-2006, the patient was seen at the physician's office having a "shingles-like rash" from his left shoulder to the radial side of his wrist. He was diagnosed with shingles. The patient also had a temperature of 101.7, a headache and a sore throat. The patient rated his pain 1 on a scale of 0 (least) to 10 (most). It was reported that the patient does not have a history of chickenpox, and that it was unknown if the patient has a recent exposure to chickenpox or herpes zoster. There was no specimen collected for PCR and a direct fluorescent antibody was not done, no other diagnostic test or labs were performed. The boy was treated with BENADRYL and acyclovir. On 01-SEP-2006 the patient recovered. The reporter considered the shingles to be an other important medical event. Additional information is not expected.
I got the Moderna Booster shot on Dec 22nd. After two days, hives started appearing on my body. The hives area was too itchy and warm. For initial 2-3 days, I scratched a lot on these hives. Then i took Zyrtec. After taking Zyrtec, hives and itching were relieved for 1 day. I had to took Zyrtec everyday for 3 months starting from Dec 24th till end of March. I wanted to reduce Zyrtec dose, so I started bearing itching and took Zyrtec after every 2 days from April onwards. It is end of June now and I am still taking Zyrtec after every 2 days.  I never had hives in my life and all of this started after taking Moderna Booster shot. This problem is ongoing from last 6 months and i have taken so many Zyrtec till this time.
This spontaneous report was received from a nurse practitioner refers to a patient of unknown age (gender unspecified). On 22-AUG-2012, the patient was vaccinated with dose 1 of RECOMBIVAX HB (Lot # and route was not reported). On 17-SEP-2012, the patient was vaccinated with dose 2 of RECOMBIVAX HB (Lot # and route was not reported). No adverse symptoms were reported. No concomitant medications were reported. Additional information has been requested.
Swelling of face and leg thighs buttocks and whole right side of  body. There has not been any treatment or outcome yet. My face started to swell at 8;45 PM on Sat. the 24th of April and the next day which was Sunday the 25th of April my whole side had swollen up over night. There has no treatment .
MALAISE, WEAKNESS, VERTIGO LASTING 4-5 DAYS ALONG WITH  PAIN AT INJECTION SITE WITH  LARGE AREA OF ECCYMOSIS WHICH  HAS REMAINED ALMOST 3 WEEKS LATER.
Hallucinating, restless, itching all over with no visible rash.  No swelling or redness at injection site.
Nausea/vomiting persistent. Had UTI and was on macrodatntin at same time.